MedTrace Logo

Soy Formula Feedings in Healthy, Term Infants

NCT02456831 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2015-05-29

No results posted yet for this study

Summary

This study evaluates the GI tolerance and acceptability of soy formulas fed to healthy term infants with reported intolerance to a milk-based formula.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Experimental Infant Formula 1

method A phytate reduction and 5% protein hydrolysis

OTHER

Experimental Infant Formula 2

method A phytate reduction and 10% protein hydrolysis

OTHER

Experimental Infant Formula 3

method B phytate reduction and 5% protein hydrolysis

OTHER

Active Comparator: Control Infant Formula

Ready-to-Feed (RTF) Soy Infant Formula

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • John Lasekan, MBA, PhD, CCRP · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Weeks
Max Age
9 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1992-12-31
Primary Completion
1994-06-30
Completion
1994-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02456831 on ClinicalTrials.gov